Thursday, January 18, 2018 10:21:18 PM
How fortunate that almost a month ago a newly created LLC, Phoenix Biomaterials by Ronald Barnes, pays out 6 figures on "test results" and ALLM had a due date for 2 short term loans coming due in January 2018 that totaled...6 FIGURES!
You can't find 1 thing on Phoenix Biomaterials, but you can find that Mr. Barnes has filed NUMEROUS LLCs using the same address as he did for Phoenix. Heck, he created 2 on the same day;
https://www.bizapedia.com/addresses/2339-meadow-church-way-duluth-ga-30097.html
Why do you need a Phoenix Biomaterials, Thomaston and a Phoenix Biomaterials, Vidalia...on the same day? I count 16 LLCs created by Ron on this bizapedia link ( of the address they use for filing) between he and Susan Barnes (his wife?).
I told you I would find a connection between Ron and Daniel and I have;
https://phoenixrenewableresources.com/
BTW, Ron Barnes created this LLC too. The webpage has ALLM written all over it...down to the CTS process claims! Click on the partners tab and see what credentials Ron brings. It sure isn't chemical manufacturing! His wife is a partner of this company too. The company philosophy for Phoenix Biomaterials is exactly the same as Alliance BioProducts! What the hell is going on?
Still don't see what's going on here? They are looking to stay afloat and creating LLCs all over the place to help them raise short term notes to keep this ruse going. It is no coincidence that 3 LLCs were created within a month of each other and tied to ALLM. Is this what legitimate companies do?
If I didn't know better, I would say this was all being put in place once ALLM goes bankrupt to keep the game going. As an investor, you cannot ignore these "coincidences".
Recent BIOF News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 02:34:54 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 05:41:18 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 08/17/2023 01:26:03 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 05:43:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM